| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| M B Rank. Effects of growth hormone on the metabolism of lipids and water and their potential in causing adverse events during growth hormone treatment. Hormone research. vol 39. issue 3-4. 1994-01-27. PMID:8262469. |
the risks faced in acromegaly, for instance, are not necessarily shared by turner's syndrome patients treated with gh. |
1994-01-27 |
2023-08-12 |
Not clear |
| J Bertherat, P Chanson, D Dewailly, M Dupuy, P Jaquet, F Peillon, J Epelbau. Somatostatin receptors, adenylate cyclase activity, and growth hormone (GH) response to octreotide in GH-secreting adenomas. The Journal of clinical endocrinology and metabolism. vol 77. issue 6. 1994-01-24. PMID:7903312. |
to determine the cellular mechanism(s) of the variability in gh responsiveness to octreotide in acromegaly, somatostatin (srih) receptor status was studied in 37 gh-secreting adenomas. |
1994-01-24 |
2023-08-12 |
Not clear |
| K Takan. [Recent progress in diagnosis and treatment of patients with GH deficiency and GH overproduction]. Nihon rinsho. Japanese journal of clinical medicine. vol 51. issue 10. 1994-01-10. PMID:8254939. |
the diagnostic criteria of gh deficiency and acromegaly have been revised in 1990 by the ministry of health and welfare in japan. |
1994-01-10 |
2023-08-12 |
Not clear |
| K Takan. [Recent progress in diagnosis and treatment of patients with GH deficiency and GH overproduction]. Nihon rinsho. Japanese journal of clinical medicine. vol 51. issue 10. 1994-01-10. PMID:8254939. |
for the treatment of gh producing pituitary tumor (acromegaly), a long acting analog of somatostatin is now available to reduce the size of the tumor. |
1994-01-10 |
2023-08-12 |
Not clear |
| E Hosoi, Y Yokogoshi, E Hosoi, H Horie, T Sano, S Yamada, S Sait. Analysis of the Gs alpha gene in growth hormone-secreting pituitary adenomas by the polymerase chain reaction-direct sequencing method using paraffin-embedded tissues. Acta endocrinologica. vol 129. issue 4. 1993-12-17. PMID:8237246. |
we investigated the prevalence of gs alpha gene mutations in growth hormone (gh) secreting pituitary adenomas from japanese patients with acromegaly. |
1993-12-17 |
2023-08-12 |
Not clear |
| A L Jensen, M K Thomsen, H Aaes, M Andreasen, J Søndergaar. Polymorphonuclear neutrophil granulocyte chemotactic hyperresponsiveness in a case of canine acromegaly. Veterinary immunology and immunopathology. vol 37. issue 3-4. 1993-12-14. PMID:8236807. |
the purpose of the present study was to evaluate the chemotactic responsiveness of canine peripheral pmn in a dog with acromegaly, caused by spontaneous, progesterone-induced hypersecretion of gh and, secondary to this, a seven-fold increase in insulin-like growth factor i (igf-i). |
1993-12-14 |
2023-08-12 |
dog |
| G Tamburrano, M L Jaffrain-Rea, A Grossi, A Lise, C Bullett. [Familial acromegaly. Apropos of a case. Review of the literature]. Annales d'endocrinologie. vol 53. issue 5-6. 1993-12-08. PMID:1364120. |
despite basal plasma gh levels ranging from 8.00 to 10.00 ng/ml in 3 other family members, the normality of both gh response to induced-hyperglycemia and ct-imaging of the pituitary gland excluded the diagnosis of acromegaly in these subjects. |
1993-12-08 |
2023-08-11 |
human |
| O Dohán, M Góth, I Szabolcs, L Kovács, Z Kovács, G Szilágy. [The place of insulin-like growth factor I in the diagnosis of acromegaly]. Orvosi hetilap. vol 134. issue 42. 1993-12-06. PMID:8233444. |
insulin-like growth factor-i (igf-i) and basal growth hormone (gh) (average of gh values measured at -20 an 0 minutes) levels were measured in 32 (29 treated, 3 untreated) patients with acromegaly. |
1993-12-06 |
2023-08-12 |
Not clear |
| O Dohán, M Góth, I Szabolcs, L Kovács, Z Kovács, G Szilágy. [The place of insulin-like growth factor I in the diagnosis of acromegaly]. Orvosi hetilap. vol 134. issue 42. 1993-12-06. PMID:8233444. |
compared to this, the basal gh level proved to be a much less reliable indicator to predict or exclude active acromegaly (sensitivity: 0.7, specificity: 1, positive predictive value: 1, negative predictive value: 0.75). |
1993-12-06 |
2023-08-12 |
Not clear |
| M Mauri, A M Picó, R Alfayate, J R Dominguez, R Cámara, C Miralle. Usefulness of urinary growth hormone (GH) measurement for evaluating endogenous GH secretion in acromegaly. Hormone research. vol 39. issue 1-2. 1993-11-10. PMID:8406334. |
usefulness of urinary growth hormone (gh) measurement for evaluating endogenous gh secretion in acromegaly. |
1993-11-10 |
2023-08-12 |
Not clear |
| M Mauri, A M Picó, R Alfayate, J R Dominguez, R Cámara, C Miralle. Usefulness of urinary growth hormone (GH) measurement for evaluating endogenous GH secretion in acromegaly. Hormone research. vol 39. issue 1-2. 1993-11-10. PMID:8406334. |
in conclusion, u-gh appears to be a simple, noninvasive and inexpensive test for evaluating gh secretion in active acromegaly. |
1993-11-10 |
2023-08-12 |
Not clear |
| S Ohashi, H Kaji, H Abe, K Chihar. "Paradoxical" GH suppression by secretagogues in acromegaly? Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. vol 25. issue 7. 1993-11-08. PMID:8406329. |
"paradoxical" gh suppression by secretagogues in acromegaly? |
1993-11-08 |
2023-08-12 |
Not clear |
| D K Alster, C Y Bowers, C A Jaffe, P J Ho, A L Barka. The growth hormone (GH) response to GH-releasing peptide (His-DTrp-Ala-Trp-DPhe-Lys-NH2), GH-releasing hormone, and thyrotropin-releasing hormone in acromegaly. The Journal of clinical endocrinology and metabolism. vol 77. issue 3. 1993-10-14. PMID:8370708. |
the growth hormone (gh) response to gh-releasing peptide (his-dtrp-ala-trp-dphe-lys-nh2), gh-releasing hormone, and thyrotropin-releasing hormone in acromegaly. |
1993-10-14 |
2023-08-12 |
Not clear |
| D K Alster, C Y Bowers, C A Jaffe, P J Ho, A L Barka. The growth hormone (GH) response to GH-releasing peptide (His-DTrp-Ala-Trp-DPhe-Lys-NH2), GH-releasing hormone, and thyrotropin-releasing hormone in acromegaly. The Journal of clinical endocrinology and metabolism. vol 77. issue 3. 1993-10-14. PMID:8370708. |
in patients with acromegaly, gh-producing pituitary tumors release gh in response to specific stimuli such as gh-releasing hormone (ghrh) and are also responsive to a variety of nonspecific stimuli, such as trh or gnrh, and may exhibit paradoxical responses to glucose and dopamine. |
1993-10-14 |
2023-08-12 |
Not clear |
| D K Alster, C Y Bowers, C A Jaffe, P J Ho, A L Barka. The growth hormone (GH) response to GH-releasing peptide (His-DTrp-Ala-Trp-DPhe-Lys-NH2), GH-releasing hormone, and thyrotropin-releasing hormone in acromegaly. The Journal of clinical endocrinology and metabolism. vol 77. issue 3. 1993-10-14. PMID:8370708. |
we studied the gh responses to ghrh, ghrp, and trh stimulation in 11 patients with active acromegaly. |
1993-10-14 |
2023-08-12 |
Not clear |
| D K Alster, C Y Bowers, C A Jaffe, P J Ho, A L Barka. The growth hormone (GH) response to GH-releasing peptide (His-DTrp-Ala-Trp-DPhe-Lys-NH2), GH-releasing hormone, and thyrotropin-releasing hormone in acromegaly. The Journal of clinical endocrinology and metabolism. vol 77. issue 3. 1993-10-14. PMID:8370708. |
in conclusion, in patients with acromegaly, the gh response to ghrp is qualitatively normal and does not appear to depend on ghrh. |
1993-10-14 |
2023-08-12 |
Not clear |
| S Melme. Medical management of acromegaly--what and when? Acta endocrinologica. vol 129 Suppl 1. 1993-10-14. PMID:8372605. |
gh and igf-i levels are elevated in patients with acromegaly. |
1993-10-14 |
2023-08-12 |
Not clear |
| M Yamada, T Monden, T Satoh, N Satoh, M Murakami, T Iriuchijima, T Kakegawa, M Mor. Pituitary adenomas of patients with acromegaly express thyrotropin-releasing hormone receptor messenger RNA: cloning and functional expression of the human thyrotropin-releasing hormone receptor gene. Biochemical and biophysical research communications. vol 195. issue 2. 1993-10-12. PMID:8396925. |
the sequence and functioning analyses showed the same expression of trh-r mrna in the pituitary adenomas as that in the normal pituitaries, indicating that 1) some adenomas of patients with acromegaly express an intact and functional trh-r, and that 2) the paradoxical response of gh secretion to trh found in the patients might be a direct effect of trh on trh-r expressed in the adenoma. |
1993-10-12 |
2023-08-12 |
mouse |
| S Yamada, T Aiba, T Sano, K Kovacs, Y Shishiba, S Sawano, K Takad. Growth hormone-producing pituitary adenomas: correlations between clinical characteristics and morphology. Neurosurgery. vol 33. issue 1. 1993-09-23. PMID:7689191. |
sg adenomas more frequently affected younger women, but no significant correlation was found between the adenoma type and the characteristic signs and symptoms of acromegaly, the incidence of diabetes mellitus or hypertension, or the basal serum gh and insulin-like growth factor i levels. |
1993-09-23 |
2023-08-12 |
Not clear |
| R D Dobrashian, D J O'Halloran, A Hunt, C G Beardwell, S M Shale. Relationships between insulin-like growth factor-1 levels and growth hormone concentrations during diurnal profiles and following oral glucose in acromegaly. Clinical endocrinology. vol 38. issue 6. 1993-08-23. PMID:8334745. |
the aim of this study was to refine the biochemical definition of disease activity in acromegaly by comparing serum growth hormone (gh) measurements during a 10-hour day profile with serum gh values during an oral glucose tolerance test. |
1993-08-23 |
2023-08-12 |
Not clear |